SAI
RMD icon

Savvy Advisors Inc’s ResMed RMD Stock Holding History

Savvy Advisors Inc’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$264K Sell
1,175
-147
-11% -$36.6K 0.01% 931
2025
Q4 		$318K Buy
+1,322
New +$338K 0.01% 749

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Savvy Advisors Inc's RMD Position: Q1 2026 in Review

Savvy Advisors Inc reduced its ResMed (RMD) stake by 11% in Q1 2026, selling an estimated $36.6K and leaving 1,175 shares worth $264K. The position accounts for 0.01% of the portfolio, ranked #931.

Savvy Advisors Inc first reported a position in RMD in Q4 2025 and has held it in 2 quarters since. The position peaked at $318K in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Savvy Advisors Inc held 1,175 shares of ResMed worth $264K as of Q1 2026.
  • Savvy Advisors Inc sold 147 ResMed shares in Q1 2026, an estimated $36.6K.
  • ResMed made up 0.01% of Savvy Advisors Inc's portfolio in Q1 2026, its #931 holding.
  • Savvy Advisors Inc first reported a position in ResMed in Q4 2025 and has held it in 2 quarters since.
  • Savvy Advisors Inc's ResMed position peaked at $318K in Q4 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Savvy Advisors Inc's 13F filing for Q1 2026, filed 11 May 2026.